Association of ITPA gene variants and ribavirin-related anemia in Han Chinese with chronic hepatitis C genotype 1 infection
Shen, T.T.; Zheng, C.; Xie, L.F.; Xu, L.L.; Zhang, Q.
Zhonghua Gan Zang Bing Za Zhi 26(6): 463-465
2018
ISSN/ISBN: 1007-3418 PMID: 30317763 Accession: 065704330
PDF emailed within 1 workday: $29.90
Related References
Murakawa, M.; Asahina, Y.; Nagata, H.; Nakagawa, M.; Kakinuma, S.; Nitta, S.; Kawai-Kitahata, F.; Otani, S.; Kaneko, S.; Miyoshi, M.; Tsunoda, T.; Asano, Y.; Sato, A.; Itsui, Y.; Azuma, S.; Nouchi, T.; Furumoto, Y.; Asano, T.; Chuganji, Y.; Tohda, S.; Watanabe, M. 2017: ITPA gene variation and ribavirin-induced anemia in patients with genotype 2 chronic hepatitis C treated with sofosbuvir plus ribavirin Hepatology Research: the Official Journal of the Japan Society of Hepatology 47(11): 1212-1218Murakawa, M.; Asahina, Y.; Nagata, H.; Nakagawa, M.; Kakinuma, S.; Nitta, S.; Kawai-Kitahata, F.; Otani, S.; Kaneko, S.; Miyoshi, M.; Tsunoda, T.; Asano, Y.; Sato, A.; Itsui, Y.; Azuma, S.; Nouchi, T.; Furumoto, Y.; Asano, T.; Chuganji, Y.; Tohda, S.; Watanabe, M. 2017: ITPA gene variation and ribavirin-induced anemia in patients with genotype 2 chronic hepatitis C treated with sofosbuvir plus ribavirin Hepatology Research: the Official Journal of the Japan Society of Hepatology 47(11): 1212-1218
Nakagawa, M.; Sakamoto, N.; Watanabe, T.; Nishimura-Sakurai, Y.; Onozuka, I.; Azuma, S.; Kakinuma, S.; Nitta, S.; Kiyohashi, K.; Kusano-Kitazume, A.; Murakawa, M.; Yoshino, K.; Itsui, Y.; Tanaka, Y.; Mizokami, M.; Watanabe, M. 2013: Association of ITPA gene variation and serum ribavirin concentration with a decline in blood cell concentrations during pegylated interferon-alpha plus ribavirin therapy for chronic hepatitis C Hepatology International 7(1): 153-161
Kurosaki, M.; Tanaka, Y.; Nishida, N.; Sakamoto, N.; Enomoto, N.; Matsuura, K.; Asahina, Y.; Nakagawa, M.; Watanabe, M.; Sakamoto, M.; Maekawa, S.; Tokunaga, K.; Mizokami, M.; Izumi, N. 2013: Model incorporating the ITPA genotype identifies patients at high risk of anemia and treatment failure with pegylated-interferon plus ribavirin therapy for chronic hepatitis C Journal of Medical Virology 85(3): 449-458
Thompson, A.J.; Fellay, J.; Patel, K.; Tillmann, H.L.; Naggie, S.; Ge, D.; Urban, T.J.; Shianna, K.V.; Muir, A.J.; Fried, M.W.; Afdhal, N.H.; Goldstein, D.B.; McHutchison, J.G. 2010: Variants in the ITPA gene protect against ribavirin-induced hemolytic anemia and decrease the need for ribavirin dose reduction Gastroenterology 139(4): 1181-1189
El Raziky, M.; Zayed, N.A.; Abdel Baki, A.; Mansour, S.A.; Shahin, R.M.H. 2017: ITPA gene polymorphism (94C>A) effects on ribavirin-induced anemia during therapy in Egyptian patients with chronic hepatitis C Journal of Medical Virology 89(10): 1823-1829
Nemr, N.; Kishk, R.; Mandour, M. 2016: Role of ITPA gene polymorphism in ribavirin-induced anemia and thrombocytopenia in Egyptian patients with chronic hepatitis C Indian Journal of Gastroenterology: Official Journal of the Indian Society of Gastroenterology 35(1): 7-13
Domingo, P.; Guardiola, J.M.; Salazar, J.; Torres, F.; Mateo, M.Gracia.; Pacho, C.; Del Mar Gutierrez, M.; Lamarca, K.; Fontanet, A.; Martin, J.; Muñoz, J.; Vidal, F.; Baiget, M. 2012: Association of ITPA gene polymorphisms and the risk of ribavirin-induced anemia in HIV/hepatitis C virus (HCV)-coinfected patients receiving HCV combination therapy Antimicrobial Agents and ChemoTherapy 56(6): 2987-2993
Tanaka, Y.; Kurosaki, M.; Nishida, N.; Sugiyama, M.; Matsuura, K.; Sakamoto, N.; Enomoto, N.; Yatsuhashi, H.; Nishiguchi, S.; Hino, K.; Hige, S.; Itoh, Y.; Tanaka, E.; Mochida, S.; Honda, M.; Hiasa, Y.; Koike, A.; Sugauchi, F.; Kaneko, S.; Izumi, N.; Tokunaga, K.; Mizokami, M. 2011: Genome-wide association study identified ITPA/DDRGK1 variants reflecting thrombocytopenia in pegylated interferon and ribavirin therapy for chronic hepatitis C Human Molecular Genetics 20(17): 3507-3516
Sakamoto, N.; Tanaka, Y.; Nakagawa, M.; Yatsuhashi, H.; Nishiguchi, S.; Enomoto, N.; Azuma, S.; Nishimura-Sakurai, Y.; Kakinuma, S.; Nishida, N.; Tokunaga, K.; Honda, M.; Ito, K.; Mizokami, M.; Watanabe, M. 2010: ITPA gene variant protects against anemia induced by pegylated interferon-α and ribavirin therapy for Japanese patients with chronic hepatitis C Hepatology Research: the Official Journal of the Japan Society of Hepatology 40(11): 1063-1071
Clark, P J.; Aghemo, A; Degasperi, E; Galmozzi, E; Thompson, A J.; Patel, K; Rumi, M Grazia; Prati, G.; Colombo, M 2012: Sa1093 Inosine Triphosphastase (ITPA) Variants Predict Treatment-Induced Anemia, Ribavirin Dose-Reduction and Need for Erythropoietin Support During Peginterferon/Ribavirin Therapy for Chronic HCV Gastroenterology 142(5): S-967-S-968
Kucherenko, A.; Pampukha, V.; Bobrova I; Moroz, L.; Livshits, L. 2015: ITPA gene variant may protect against anemia induced during pegylated interferon alfa and ribavirin combination treatment in Ukrainian patients with chronic hepatitis C Tsitologiia i Genetika 49(2): 38-41
D'Avolio, A.; De Nicolò, A.; Cusato, J.; Ciancio, A.; Boglione, L.; Strona, S.; Cariti, G.; Troshina, G.; Caviglia, G.Paolo.; Smedile, A.; Rizzetto, M.; Di Perri, G. 2013: Association of ITPA polymorphisms rs6051702/rs1127354 instead of rs7270101/rs1127354 as predictor of ribavirin-associated anemia in chronic hepatitis C treated patients Antiviral Research 100(1): 114-119
Poordad, F.; Lawitz, E.; Reddy, K.R.; Afdhal, N.H.; Hézode, C.; Zeuzem, S.; Lee, S.S.; Calleja, J.L.; Brown, R.S.; Craxi, A.; Wedemeyer, H.; Nyberg, L.; Nelson, D.R.; Rossaro, L.; Balart, L.; Morgan, T.R.; Bacon, B.R.; Flamm, S.L.; Kowdley, K.V.; Deng, W.; Koury, K.J.; Pedicone, L.D.; Dutko, F.J.; Burroughs, M.H.; Alves, K.; Wahl, J.; Brass, C.A.; Albrecht, J.K.; Sulkowski, M.S.; Bailey, R.; Cooper, C.; Feinman, S.V.; Lee, S.; Marotta, P.; Tam, E.; Wong, F.; Bourliere, M.; Bronowicki, J.-P.; Hezode, C.; Tran, A.; Goeser, T.; Klass, D.; Schmid, R.; Wedemeyer, H.; Zeuzem, S.; Craxi, A.; Pirisi, M.; Zuin, M.; Calleja, J.L.; Afdhal, N.; Bacon, B.; Balart, L.; Bennett, M.; Bernstein, D.; Box, T.; Boyer, T.; Brown, R.; Clain, D.; Crippin, J.; Da 2013: Effects of ribavirin dose reduction vs erythropoietin for boceprevir-related anemia in patients with chronic hepatitis C virus genotype 1 infection--a randomized trial Gastroenterology 145(5): 1035-1044.E5
Yee, L.J.; Perez, K.A.; Tang, J.; Van Leeuwen, D.J.; Kaslow, R.A. 2001: Association of CTLA4 gene variants with sustained response to interferon+ribavirin therapy for chronic hepatitis C virus infection Hepatology 34(4 Pt 2): 417A
Sakamoto, N.; Tanaka, Y.; Nakagawa, M.; Yatsuhashi, H.; Nishiguchi, S.; Enomoto, N.; Azuma, S.; Nishimura-Sakurai, Y.; Kakinuma, S.; Nishida, N.; Tokunaga, K.; Mizokami, M.; Watanabe, M. 2011: 469 Itpa Gene Variant Protects Against Treatment-Induced Anemia and Improves Viral Clearance by Pegylated Interferon-Alfa and Ribavirin Therapy in Chronic Hepatitis C Patients Journal of Hepatology 54: S191-S192
Peltenburg, N.C.; Bakker, J.A.; Vroemen, W.H.M.; de Knegt, R.J.; Leers, M.P.G.; Bierau, J.ör.; Verbon, A. 2015: Inosine triphosphate pyrophosphohydrolase activity: more accurate predictor for ribavirin-induced anemia in hepatitis C infected patients than ITPA genotype Clinical Chemistry and Laboratory Medicine 53(12): 2021-2029
Naggie, S.; Rallon, N.I.; Benito, J.é M.; Morello, J.; Rodriguez-Novoa, S.; Clark, P.J.; Thompson, A.J.; Shianna, K.V.; Vispo, E.; McHutchison, J.G.; Goldstein, D.B.; Soriano, V. 2012: Variants in the ITPA gene protect against ribavirin-induced hemolytic anemia in HIV/HCV-coinfected patients with all HCV genotypes Journal of Infectious Diseases 205(3): 376-383
Tsubota, A.; Shimada, N.; Abe, H.; Yoshizawa, K.; Agata, R.; Yumoto, Y.; Ika, M.; Namiki, Y.; Nagatsuma, K.; Matsudaira, H.; Fujise, K.; Tada, N.; Aizawa, Y. 2012: Several factors including ITPA polymorphism influence ribavirin-induced anemia in chronic hepatitis C World Journal of Gastroenterology 18(41): 5879-5888
Scherzer, T.-M.; Stättermayer, A.F.; Stauber, R.; Maieron, A.; Strasser, M.; Laferl, H.; Schwarzer, R.; Datz, C.; Rutter, K.; Beinhardt, S.; Steindl-Munda, P.; Hofer, H.; Ferenci, P. 2013: Effect of gender and ITPA polymorphisms on ribavirin-induced anemia in chronic hepatitis C patients Journal of Hepatology 59(5): 964-971